Walgreens Boots Alliance (WBA) Projected to Post Quarterly Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBA) will likely be releasing its earnings data before the market opens on Thursday, March 27th. Analysts expect Walgreens Boots Alliance to post earnings of $0.53 per share and revenue of $37.90 billion for the quarter. Walgreens Boots Alliance has set its FY 2025 guidance at 1.400-1.800 EPS and its FY25 guidance at $1.40-$1.80 EPS.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.66 earnings per share. On average, analysts expect Walgreens Boots Alliance to post $2 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Walgreens Boots Alliance Stock Up 0.5 %

NASDAQ:WBA opened at $11.15 on Tuesday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance has a twelve month low of $8.08 and a twelve month high of $22.05. The company has a market cap of $9.64 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. The company’s 50 day moving average is $10.94 and its two-hundred day moving average is $9.85.

Wall Street Analyst Weigh In

Several analysts have weighed in on WBA shares. StockNews.com initiated coverage on Walgreens Boots Alliance in a research note on Tuesday, March 18th. They set a “hold” rating on the stock. Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Finally, Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.